Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Medical Sciences (Basel, Switzerland)|January 30, 2019
An Exploratory Study of Inflammatory Bowel Disease and the Psychosocial Factors Affecting Health-Related Quality of LifeNirmala Sarwan, Ricardo Jurawan, Rudrunath Singh, et al.Internal Medicine Journal|June 22, 2023
Predicting length of stay for acute medical admissions in New Zealand: the MALICE scoreLomani A O'Hagan, Theodore Sutedja, Sai Konan, et al.Cardiovascular Research|June 10, 2009
Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytesYing Li, Yanwen Li, Qingping Feng, et al.Circulation|January 4, 2008
Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary DiseaseMarcello Tonelli, Frank Sacks, Malcolm Arnold, et al.The New Zealand Medical Journal|August 11, 2020
Challenges for the future: the gastroenterology specialist workforce in New ZealandRosemary Stamm, Kristina Aluzaite, Malcolm Arnold, et al.The Canadian Journal of Cardiology|May 28, 2008
Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?J Malcolm Arnold, David H Fitchett, Jonathan G Howlett, et al.American Journal of Hypertension|August 3, 2016
Coffee-Antihypertensive Drug Interaction: A Hemodynamic and Pharmacokinetic Study With FelodipineDavid G Bailey, George K Dresser, Brad L Urquhart, et al.Pharmacology Research & Perspectives|October 4, 2017
Coffee inhibition of CYP3A4 in vitro was not translated to a grapefruit-like pharmacokinetic interaction clinicallyGeorge K Dresser, Brad L Urquhart, Julianne Proniuk, et al.Current Opinion in Cardiology|December 24, 2008
Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial designAnthony S Tang, George A Wells, Malcolm Arnold, et al.Diabetes|September 14, 2011
Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetesYing Li, Jian Ma, Huaqing Zhu, et al.Pageof 3